Literature DB >> 35129140

Extrarenal Anaplastic Wilms Tumor: A Case Report With Genomic Analysis and Tumor Models.

Kelsi R Willis1, Adwait A Sathe2, Chao Xing2,3,4, Prasad Koduru1, Maddy Artunduaga3,5, Erin B Butler4, Jason Y Park1,5, Raushan T Kurmasheva6,7, Peter J Houghton6,7, Kenneth S Chen4,5, Dinesh Rakheja1,5.   

Abstract

Primary extrarenal Wilms tumors are rare neoplasms that are presumed to arise from metanephric or mesonephric remnants outside of the kidney. Their pathogenesis is debated but has not been studied, and there are no reports of genomic descriptions of extrarenal Wilms tumors. We describe a diffusely anaplastic extrarenal Wilms tumor that occurred in the lower abdomen and upper pelvis of a 10-year-old boy. In addition to the clinical, histopathologic, and radiologic features, we describe the cytogenetic changes and exomic profile of the tumor. The tumor showed loss of the tumor suppressor AMER1, loss of chromosome regions 1p, 16q, and 22q, gain of chromosome 8, and loss of function TP53 mutation-findings known to occur in renal Wilms tumors. This is the first description of the exomic profile of a primary extrarenal Wilms tumor. Our data indicate that primary extrarenal Wilms tumors may follow the same pathogenetic pathways that are seen in renal Wilms tumors. Finally, we describe the establishment of first ever tumor models (primary cell line and patient-derived xenograft) from an extrarenal Wilms tumor.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35129140      PMCID: PMC9035038          DOI: 10.1097/MPH.0000000000002413

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.170


  57 in total

1.  Extrarenal Wilms tumor of the left ovary: a case report.

Authors:  F Pereira; E Carrascal; C Cañas; L Flórez
Journal:  J Pediatr Hematol Oncol       Date:  2000 Jan-Feb       Impact factor: 1.289

Review 2.  Extrarenal Wilms' tumor of the uterine corpus.

Authors:  J McAlpine; M Azodi; D O'Malley; M Kelly; G Golenewsky; M Martel; T Rutherford; F Tavassoli
Journal:  Gynecol Oncol       Date:  2005-03       Impact factor: 5.482

3.  An extrarenal Wilms' tumour arising from an undescended testis.

Authors:  J Ho; L Ma; K C Wong
Journal:  Pathology       Date:  1981-07       Impact factor: 5.306

4.  From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.

Authors:  Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo
Journal:  Curr Protoc Bioinformatics       Date:  2013

5.  Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.

Authors:  Amy L Walz; Ariadne Ooms; Samantha Gadd; Daniela S Gerhard; Malcolm A Smith; Jaime M Guidry Auvil; Jamie M Guidry Auvil; Daoud Meerzaman; Qing-Rong Chen; Chih Hao Hsu; Chunhua Yan; Cu Nguyen; Ying Hu; Reanne Bowlby; Denise Brooks; Yussanne Ma; Andrew J Mungall; Richard A Moore; Jacqueline Schein; Marco A Marra; Vicki Huff; Jeffrey S Dome; Yueh-Yun Chi; Charles G Mullighan; Jing Ma; David A Wheeler; Oliver A Hampton; Nadereh Jafari; Nicole Ross; Julie M Gastier-Foster; Elizabeth J Perlman
Journal:  Cancer Cell       Date:  2015-02-09       Impact factor: 31.743

6.  Primary extrarenal Wilms' tumor in children.

Authors:  B H Broecker; A A Caldamone; N B McWilliams; H Maurer; A Salzberg
Journal:  J Pediatr Surg       Date:  1989-12       Impact factor: 2.545

Review 7.  Wilms Tumor of the Ovary: Review of the Literature and Report of 2 Cases.

Authors:  Gulisa Turashvili; Daniel J Fix; Robert A Soslow; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2020-01       Impact factor: 3.326

8.  Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.

Authors:  Giovana T Torrezan; Elisa N Ferreira; Adriana M Nakahata; Bruna D F Barros; Mayra T M Castro; Bruna R Correa; Ana C V Krepischi; Eloisa H R Olivieri; Isabela W Cunha; Uri Tabori; Paul E Grundy; Cecilia M L Costa; Beatriz de Camargo; Pedro A F Galante; Dirce M Carraro
Journal:  Nat Commun       Date:  2014-06-09       Impact factor: 14.919

9.  TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.

Authors:  Mariana Maschietto; Richard D Williams; Tasnim Chagtai; Sergey D Popov; Neil J Sebire; Gordan Vujanic; Elizabeth Perlman; James R Anderson; Paul Grundy; Jeffrey S Dome; Kathy Pritchard-Jones
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

10.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.

Authors:  Eric Talevich; A Hunter Shain; Thomas Botton; Boris C Bastian
Journal:  PLoS Comput Biol       Date:  2016-04-21       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.